CONCLUSIONS
injuries
DISEASE, ADVERSE EFFECTS, CERVICAL CANCER
The results of this study conclude that the Barbatimão gynecological ointment with and without silver nanoparticles does not have a risk to human health since no adverse effects were observed or harmful to human health. The ointment tested here has anti-inflammatory activity, proven through the result of oncotic cytology in a liquid medium and visual inspection tests of the cervix before and after use. Therefore, the results in this study demonstrated that the proposed topical formulation is safe for use in the cervix during the weeks of use investigated.For the purposes of the development of new research, new clinical trials must be carried out applied to different clinical stages of cervical cancer and investigation of the prognosis in the treatment of the disease. With this research, it is expected that the product will contribute to reduce the number of injuries that evolve into more serious forms, preventing women from being subjected to more invasive and painful procedures, in addition to enabling a reduction in public spending.
